James O. Wilson

Array ( [id] => 3794899 [patent_doc_number] => 05726302 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-03-10 [patent_title] => 'Water soluble adenosine kinase inhibitors' [patent_app_type] => 1 [patent_app_number] => 8/473492 [patent_app_country] => US [patent_app_date] => 1995-06-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 18037 [patent_no_of_claims] => 43 [patent_no_of_ind_claims] => 11 [patent_words_short_claim] => 16 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/726/05726302.pdf [firstpage_image] =>[orig_patent_app_number] => 473492 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3889852 [patent_doc_number] => 05723673 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-03-03 [patent_title] => 'Process for preparing amides of N-alkyl polyhydroxyalkyls' [patent_app_type] => 1 [patent_app_number] => 8/474857 [patent_app_country] => US [patent_app_date] => 1995-06-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12088 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 113 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/723/05723673.pdf [firstpage_image] =>[orig_patent_app_number] => 474857 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3775828 [patent_doc_number] => 05808045 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-09-15 [patent_title] => 'Compositions for enzyme catalyzed template-independent creation of phosphodiester bonds using protected nucleotides' [patent_app_type] => 1 [patent_app_number] => 8/486897 [patent_app_country] => US [patent_app_date] => 1995-06-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 17498 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 37 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/808/05808045.pdf [firstpage_image] =>[orig_patent_app_number] => 486897 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3941391 [patent_doc_number] => 05872244 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-02-16 [patent_title] => '3\' protected nucleotides for enzyme catalyzed template-independent creation of phosphodiester bonds' [patent_app_type] => 1 [patent_app_number] => 8/486535 [patent_app_country] => US [patent_app_date] => 1995-06-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 17542 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 47 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/872/05872244.pdf [firstpage_image] =>[orig_patent_app_number] => 486535 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3690226 [patent_doc_number] => 05696251 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-12-09 [patent_title] => 'Non-nucleotide linking reagents for nucleotide probes' [patent_app_type] => 1 [patent_app_number] => 8/485629 [patent_app_country] => US [patent_app_date] => 1995-06-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 20 [patent_figures_cnt] => 20 [patent_no_of_words] => 14056 [patent_no_of_claims] => 49 [patent_no_of_ind_claims] => 13 [patent_words_short_claim] => 14 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/696/05696251.pdf [firstpage_image] =>[orig_patent_app_number] => 485629 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3926502 [patent_doc_number] => 05945524 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-08-31 [patent_title] => 'Process for the chemical synthesis of oligonucleotides' [patent_app_type] => 1 [patent_app_number] => 8/487229 [patent_app_country] => US [patent_app_date] => 1995-06-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7183 [patent_no_of_claims] => 42 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 29 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/945/05945524.pdf [firstpage_image] =>[orig_patent_app_number] => 487229 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3525162 [patent_doc_number] => 05527803 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1996-06-18 [patent_title] => '9-purinyl phosphonic acid derivatives' [patent_app_type] => 1 [patent_app_number] => 8/469097 [patent_app_country] => US [patent_app_date] => 1995-06-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11442 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 291 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/527/05527803.pdf [firstpage_image] =>[orig_patent_app_number] => 469097 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4146804 [patent_doc_number] => 06103084 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-08-15 [patent_title] => 'Apparatus for electroporation' [patent_app_type] => 1 [patent_app_number] => 8/469967 [patent_app_country] => US [patent_app_date] => 1995-06-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 6 [patent_no_of_words] => 5179 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 276 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/103/06103084.pdf [firstpage_image] =>[orig_patent_app_number] => 469967 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3816708 [patent_doc_number] => 05770584 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-06-23 [patent_title] => 'Method of treating hepatitis virus infections' [patent_app_type] => 1 [patent_app_number] => 8/465947 [patent_app_country] => US [patent_app_date] => 1995-06-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 12879 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 137 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/770/05770584.pdf [firstpage_image] =>[orig_patent_app_number] => 465947 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4182633 [patent_doc_number] => 06020326 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-02-01 [patent_title] => 'Method for inhibition of bone growth by anionic polymers' [patent_app_type] => 1 [patent_app_number] => 8/469560 [patent_app_country] => US [patent_app_date] => 1995-06-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 22 [patent_no_of_words] => 13155 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 11 [patent_words_short_claim] => 23 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/020/06020326.pdf [firstpage_image] =>[orig_patent_app_number] => 469560 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3516182 [patent_doc_number] => 05576302 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1996-11-19 [patent_title] => 'Oligonucleotides for modulating hepatitis C virus having phosphorothioate linkages of high chiral purity' [patent_app_type] => 1 [patent_app_number] => 8/468447 [patent_app_country] => US [patent_app_date] => 1995-06-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11803 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 28 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/576/05576302.pdf [firstpage_image] =>[orig_patent_app_number] => 468447 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3861263 [patent_doc_number] => 05792847 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-08-11 [patent_title] => '2\' Modified Oligonucleotides' [patent_app_type] => 1 [patent_app_number] => 8/467422 [patent_app_country] => US [patent_app_date] => 1995-06-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7785 [patent_no_of_claims] => 35 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 196 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/792/05792847.pdf [firstpage_image] =>[orig_patent_app_number] => 467422 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3634428 [patent_doc_number] => 05631245 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-05-20 [patent_title] => 'Method for medicating the inflammatory controlling system and adverse inflammatory reactions and for making compounds for treating the pathology of adverse inflammatory reactions' [patent_app_type] => 1 [patent_app_number] => 8/470501 [patent_app_country] => US [patent_app_date] => 1995-06-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3614 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 38 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/631/05631245.pdf [firstpage_image] =>[orig_patent_app_number] => 470501 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4038495 [patent_doc_number] => 05856467 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-01-05 [patent_title] => 'Genetically engineered modification of potato to form amylose-type starch' [patent_app_type] => 1 [patent_app_number] => 8/471965 [patent_app_country] => US [patent_app_date] => 1995-06-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 3542 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 62 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/856/05856467.pdf [firstpage_image] =>[orig_patent_app_number] => 471965 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3589700 [patent_doc_number] => 05585364 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1996-12-17 [patent_title] => 'Antiviral compounds' [patent_app_type] => 1 [patent_app_number] => 8/467903 [patent_app_country] => US [patent_app_date] => 1995-06-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3909 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 12 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/585/05585364.pdf [firstpage_image] =>[orig_patent_app_number] => 467903 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3590320 [patent_doc_number] => 05567688 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1996-10-22 [patent_title] => 'L-nucleosides for the treatment of hepatitis B-virus' [patent_app_type] => 1 [patent_app_number] => 8/467010 [patent_app_country] => US [patent_app_date] => 1995-06-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 9 [patent_no_of_words] => 11949 [patent_no_of_claims] => 32 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 59 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/567/05567688.pdf [firstpage_image] =>[orig_patent_app_number] => 467010 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3706242 [patent_doc_number] => 05654284 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-08-05 [patent_title] => 'Oligonucleotides for modulating RAF kinase having phosphorothioate linkages of high chiral purity' [patent_app_type] => 1 [patent_app_number] => 8/466692 [patent_app_country] => US [patent_app_date] => 1995-06-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11777 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 28 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/654/05654284.pdf [firstpage_image] =>[orig_patent_app_number] => 466692 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3871615 [patent_doc_number] => 05763417 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-06-09 [patent_title] => 'Protection from septic shock subsequent to injury by dsRNAs' [patent_app_type] => 1 [patent_app_number] => 8/469625 [patent_app_country] => US [patent_app_date] => 1995-06-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4141 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 25 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/763/05763417.pdf [firstpage_image] =>[orig_patent_app_number] => 469625 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3612475 [patent_doc_number] => 05565438 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1996-10-15 [patent_title] => 'L-nucleosides for the treatment of epstein-bar virus' [patent_app_type] => 1 [patent_app_number] => 8/466274 [patent_app_country] => US [patent_app_date] => 1995-06-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 9 [patent_no_of_words] => 11953 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 50 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/565/05565438.pdf [firstpage_image] =>[orig_patent_app_number] => 466274 [rel_patent_id] =>[rel_patent_doc_number] =>)